skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I came across PUMP, World Class Extractions, on Jan 26 had an update on Pineapple Express Delivery, they have controlling interest. They deliver Cannabis B-B, and B-C, and also Liquor in some jurisdictions. They deliver Medical Cannabis for Shoppers Drug mart , as well as for Spectrum, medical division of Canopy Growth. Now they’re applying for license from Canadian Gov for “Sale for Medical Purposes “ for its facility in GTA. They seem relatively undiscovered, but getting attention lately. Do you think they could be a good Aquisition target by Shoppers or Canopy Growth, or any other bigger player for that matter.
Plus in their own business in the CBD products and devices could also be attractive part to the package
Thanks
Read Answer Asked by Allen on February 12, 2021
Q: Enjoyed your article on year end tax selling,i picked the 9 stocks with the greatest estimated revenue growth for 2021 of these 9 could you pick your top 5 which have the best chance of a turnaround for 2021, could you rank them for growth and risk, thank you use extra credits if needed
Read Answer Asked by Greg on December 16, 2020
Q: I bought into both of these companies last year and am down about 50% (along with the rest of the sector). In spite of the overall sector performance what would be your expectation of these 2 companies for this year and next? Should I get out while there is still something left and reinvest into something considerably less volatile or is there a chance these companies can still make a comeback in the short term?? Thanks
Read Answer Asked by Rob on February 18, 2020
Q: Hi there, I recently watched an episode of Market Call and I believe Bruce Campbell from Campbell Lee and Ross said he has a position and it was more interesting than growers from the oil perspective. Would you agree and would you be comfortable taking a small position in this name? What about in comparison to another company that is somewhat related to the space such was Enwave? Thank you!
Read Answer Asked by Michael on July 17, 2019
Q: This company continues to make the headlines with new contracts and good news... I know it is a Cannabis company which is overvalued based on current sales, revenue earnings etc, but they have a low P/S in relation to peers, positive EBITDA and positive cash flow from operations).

I own it already and recently asked a question after their 2nd quarter. Today they announce at $30 million agreement with Cronos Group for 18 months with an additional $30 million revenue potential PLUS a separate tolling agreement (which they also offer to multiple large Cannabis companies. They are close to EU GMP facility certification which will be a big step for them for sales to Europe and for medical cannabis sales. They have hinted at CPG deals in the works and with upcoming vape pens and edibles etc being legal in the fall it seems like there are lots of positive catalysts for this stock in particular. What to you would be a good way to value this type of company which focuses on extraction not dried flower sales. What are your thoughts on the recent deal announced?
Read Answer Asked by Michael on May 15, 2019
Q: HI Team,
Could you please comment on Medipharm's recent Q1 earnings. The market reaction appears flat with a run up beforehand. Growth looks good and I like the model, though have a hard time wrapping my head around the current valuation of around 700M, having only a couple small properties (one in Barrie and one in Australia) with apprx 60 employees. I know this market is inflated, however I believe the extract business is a good play. Is Medipharm a strong front runner in Canada in its field? What do you think of its valuation compared to its potential growth as well as its current earnings?

Cheers,
Read Answer Asked by Ryan on May 10, 2019
Q: Hello, can you share your thoughts on Medipharm Labs Corp's recent earnings release?Seems to be positive news, good revenue all in the last month or 2, future contracts look positive. Not sure how to compare these financials to other companies like weed or acb, because Medipharm is focused mainly on Cannabis Concentrates. Thanks!
Read Answer Asked by Michael on April 04, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!